| 2024-04-08 21:26 | CC:METX | ME Therapeutics Holdings Inc | 3.51 | News Release200 | ME Therapeutics grants option to buy 250,000 shares |
| 2024-03-22 22:04 | CC:METX | ME Therapeutics Holdings Inc | 3.33 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-03-22 21:01 | CC:METX | ME Therapeutics Holdings Inc | 3.33 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-03-06 11:12 | CC:METX | ME Therapeutics Holdings Inc | 3.05 | News Release200 | ME Therapeutics closes $1.55-million private placement |
| 2024-02-27 14:26 | CC:METX | ME Therapeutics Holdings Inc | 6.35 | News Release200 | ME does not say why stock is up; arranges financing |
| 2024-01-25 18:13 | CC:METX | ME Therapeutics Holdings Inc | 1.01 | News Release200 | ME completes in-life part of non-GLP toxicology study |
| 2024-01-24 17:14 | CC:METX | ME Therapeutics Holdings Inc | 1.30 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-01-24 17:14 | CC:METX | ME Therapeutics Holdings Inc | 1.30 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-12-19 19:05 | CC:METX | ME Therapeutics Holdings Inc | 1.00 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-12-19 19:05 | CC:METX | ME Therapeutics Holdings Inc | 1.00 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-12-11 11:44 | CC:METX | ME Therapeutics Holdings Inc | 0.81 | News Release200 | ME Therapeutics lists on Frankfurt Stock Exchange |
| 2023-12-05 09:24 | CC:METX | ME Therapeutics Holdings Inc | 0.79 | News Release200 | ME Therapeutics details drug R&D programs |
| 2023-10-23 12:56 | CC:METX | ME Therapeutics Holdings Inc | | News Release200 | ME Therapeutics to receive $50,000 funding from NRC |
| 2023-10-11 11:38 | CC:METX | ME Therapeutics Holdings Inc | | News Release200 | ME Therapeutics to begin trading on CSE Oct. 12 |
| 2023-10-10 18:49 | CC:METX | ME Therapeutics Holdings Inc | | New Listing5 | ME Therapeutics to trade on CSE Oct. 12 |